# Epimède: portfolio, investments and team

> Epimède is a growth equity. 1 investment on record, latest Jun 2019. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/epimede (Millionrounds; every figure on the page links to its filing or article)

[Investor](https://millionrounds.com/investors)

# Epimède

Last cheque observed Jun 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet Growth equity

Series B

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 1 on record

Since the last cheque **2687** days **00** hrs **00** min **00** sec

Median round **$39M** Rounds led **0 of 1**

Pitch Epimède

## Epimède highlights

- 01 1 rounds on record
- 02 Mostly Series B: 100% of its rounds

## What they do

- **Type:** Growth equity (from a list, unverified)
- **Cheque size:** Not stated
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **1 appearances**

- **2019** 1 round
- **Jun** **[Imcyse](https://millionrounds.com/company/imcyse)** Series B · BE · FinSMEs **$39M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What they claim to have backed

From their own portfolio page (on their website)

**4** of 11 we have independently watched raise

[Endotools](https://millionrounds.com/company/endo-tools)[Imcyse](https://millionrounds.com/company/imcyse)[Ncardia](https://millionrounds.com/company/ncardia)[Novadip](https://millionrounds.com/company/novadip-biosciences) Asitbiotech Ethias Gwma Lasea Mantagraphic Radiomics Wishbone-biotech

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## The cheque

Series B

Median round joined **$39M** the round, not its cheque

Led 0 of 1 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Jun 2019

Rounds by stage said on their site

- Series B *1*

**Pitching Epimède?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Recently backed

The latest companies Epimède put money into.

[**Imcyse** $39M · Jun 2019](https://millionrounds.com/company/imcyse)

## Quick answers about Epimède

### What does Epimède invest in?

Epimède invests most often at Series B (100% of the rounds on record).

### How active is Epimède?

1 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2019.

### What has Epimède invested in recently?

Its most recent investments on record: Imcyse (Series B, Jun 2019).

### How big are Epimède's cheques?

The median round it joins is $39M.

### Is Epimède investing now?

No investments in the last 12 months; the latest was in Jun 2019.

### What kind of investor is Epimède?

Epimède is a growth equity firm.

### Where does this information on Epimède come from?

From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=epimede) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=epimede)